Antibiotic Resistant Infection: Clinical Trials

62 trials for Antibiotic Resistant Infection, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

25 completed, 22 unknown, 6 recruiting, 5 withdrawn. 14 Not applicable, 7 Phase 4, 5 Phase 3, 3 Early Phase 1, 3 Phase 2.

By phase and status

PhaseTrialsStatus
Not applicable14Completed 7, Unknown 3, Recruiting 2, Enrolling by invitation 1, Withdrawn 1
Phase 47Completed 3, Unknown 2, Withdrawn 2
Phase 35Recruiting 2, Completed 1, Terminated 1, Unknown 1
Early Phase 13Completed 1, Unknown 1, Withdrawn 1
Phase 23Completed 1, Recruiting 1, Withdrawn 1
Phase 11Terminated 1

Follow Antibiotic Resistant Infection: new trials by email Literature Review of Antibiotic Resistant Infection trials Research Report on Antibiotic Resistant Infection

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Antimicrobial Resistant Organism Decolonization After Microbiome Perturbation
MET-2, Placebo - Gram-negative Bacteremia, Microbial Colonization
Phase 2WithdrawnUniversity Health Network, Toronto2026-07-012026-03-12
Clean Trial - Chlorination to Reduce Enteric and Antibiotic Resistant Infections in Neonates
chlorination for water disinfection and surface disinfection, infection prevention and control messaging - Sepsis, Neonatal Mortality
Not applicableRecruitingUniversity of California, Berkeley454502025-01-212026-10-13
Post-Operative Antibiotic Efficacy in Clean Contaminated Head and Neck Surgery: A Randomized Controlled Trial
No Post Operative Antibiotics for intervention group, Post Operative Antibiotics for one day - Head and Neck Neoplasms, UADT Neoplasm
Not applicableEnrolling by invitationShaukat Khanum Memorial Cancer Hospital & Research Centre1702024-11-152024-12-13
The Role of Postoperative Antibiotics in Laparoscopic Cholecystectomy
IV antibiotic, Oral antibiotic - Infection Wound, Antibiotic Resistant Infection
Phase 4UnknownMinia University Hospital3002024-08-302024-09-23
Antibiotic Use and Resistance KAP Among Dental Interns
Antibiotic Side Effect, Antibiotic Resistant Infection
UnknownCairo University3432024-06-012024-04-25
Medical Device (MD) Derived Pharmacokinetic (PK) Parameters for Vancomycin (MD-PK)
Drug Infusion Pump Monitoring - Infection, Bacterial, Antibiotic Side Effect
CompletedSt George's, University of London302023-10-302025-05-18
Chinese Hospital Acquired Pneumonia Collaboration Network: Epidemiology, Diagnosis and Treatment
prognosis status - Hospital-acquired Pneumonia, Antibiotic Resistant Infection
Not yet recruitingRuijin Hospital40002023-10-012023-09-08
Effect of Antibiotics on Urinary Microbiome
Bactrim DS 800Mg-160Mg Tablet, Placebo oral tablet - Microtia, UTI
Early Phase 1WithdrawnJohns Hopkins University2023-10-012021-11-03
Dipsticks and Microscopy to Reduce Antibiotic Use in Women's Urinary Tract Infections: a Pilot Trial (MicUTI)
Point-of-care microscopy and dipstick guided management - Cystitis Acute, Antibiotic Resistant Infection
Not applicableCompletedWuerzburg University Hospital1542023-06-152024-07-24
Pivmecillinam With Amoxicillin/Clavulanic Acid for Step Down Oral Therapy in ESBL UTIs
Pivmecillinam and amoxicillin/clavulanic acid, Standard treatment, ciprofloxacin, trimethoprim/sulfamethoxazole or ertapenem depending on susceptibility - Urinary Tract Infections, Bacteremia
Phase 3RecruitingLund University3302023-05-292023-08-28
Evaluation of the Impact of the Modification of Antibiotic Susceptibility Testing on Antibiotic Prescriptions
Antibiotic - Antibiotic Resistant Infection
UnknownCentral Hospital, Nancy, France1992023-05-152023-06-13
Cholecystitis From a Microbiological and Histopathological Perspective
Microbiological and histopathological investigation of bile and gallbladder wall specimens. - Calculous Cholecystitis, Antibiotic Resistant Infection
UnknownOrgankirurgisk afdeling, sygehus lillebælt, Kolding602023-04-012024-04-15
Broad-spectrum Antibiotic Prophylaxis in Tumor and Infected Orthopedic Surgery
Standard antibiotic prophylaxis - Surgical Site Infection, Microbial Colonization
Phase 3RecruitingBalgrist University Hospital11002022-09-152024-12-02
Interventions to Decrease CRE Colonization and Transmission Between Hospitals, Households, Communities and Domesticated Animals
Hospital Cohort Care Intervention at the hospital, , Household Education Communication Hygiene Intervention, Livestock Antibiotic Intervention - Antibiotic Resistant Infection, Carbapenem-Resistant Enterobacteriaceae Infection
Not applicableRecruitingHanoi University of Public Health8002022-07-012025-06-24
Modified Surface of PLGA Nanoparticles in Smart Hydrogel
Ciprofloxacin - Antibiotic Resistant Infection
Early Phase 1CompletedBritish University In Egypt552022-04-022022-07-05
Antibiotic Impregnated Bone Graft to Reduce Infection in Hip Replacement.
Vancomycin + Tobramycin, Saline - Arthroplasty, Replacement, Hip, Osteoarthritis, Hip
Phase 2RecruitingUniversity Hospital, Linkoeping11002022-04-012026-07-10
Phenotypic Profile and Molecular Mechanism of Resistance in Carbapenemase-producing Enterobacterales and Pseudomonas Aeruginosa Isolates From Brazilian Hospitals: Implications for the Introduction of IMIPENEM-RELEBACTAM
No intervention - Bacterial Infections, Antibiotic Resistant Infection
UnknownD'Or Institute for Research and Education2502022-04-012022-03-17
The Impact of Covid-19 Hospital Care on the Prevalence of MDRO in Indonesia
Antibiotic Resistant Infection, COVID-19
UnknownErasmus Medical Center11102022-03-072022-03-24
Comprehensive Molecular Diagnosis and Management of Hospital- and Ventilator-associated Pneumonia in Norway
Molecular diagnostics in HAP and VAP - Pneumonia, Ventilator-Associated, Hospital-acquired Pneumonia
UnknownVestre Viken Hospital Trust5502021-06-152021-12-06
Imipenem/Cilastatin/Relebactam (IMI/REL) in Treatment of CRE Infections
Imipenem+Relebactam - Carbapenem-Resistant Enterobacteriaceae Infection, KPC
Phase 4WithdrawnWake Forest University Health Sciences2021-06-072024-09-04

Showing 20 of 62. Sign in to see all of them.

Narrower conditions

Bacterial Infections (6)  ·  Critical Illness (6)  ·  Infections (6)  ·  Sepsis (6)  ·  Surgical Wound Infection (5)  ·  Communicable Diseases (4)  ·  Cross Infection (4)  ·  Bacteremia (3)  ·  Enterobacteriaceae Infections (2)  ·  Healthcare-Associated Pneumonia (2)  ·  Pneumonia (2)  ·  Pneumonia, Ventilator-Associated (2)  ·  Postoperative Complications (2)  ·  Shock, Septic (2)  ·  Urinary Tract Infections (2)

Broader conditions

Infections (24)  ·  Pathologic Processes (23)  ·  Pathological Conditions, Signs and Symptoms (23)  ·  Disease Attributes (15)  ·  Bacterial Infections and Mycoses (13)  ·  Inflammation (9)  ·  Systemic Inflammatory Response Syndrome (8)  ·  Bacterial Infections (7)  ·  Iatrogenic Disease (6)  ·  Urogenital Diseases (6)  ·  Female Urogenital Diseases (5)  ·  Female Urogenital Diseases and Pregnancy Complications (5)  ·  Male Urogenital Diseases (5)  ·  Respiratory Tract Infections (5)  ·  Urologic Diseases (5)

Interventions

Anti-Bacterial Agents (4)  ·  Ciprofloxacin (4)  ·  Trimethoprim, Sulfamethoxazole Drug Combination (3)  ·  Amoxicillin (2)  ·  Amoxicillin-Potassium Clavulanate Combination (2)  ·  Clindamycin (2)  ·  Levofloxacin (2)  ·  Meropenem (2)  ·  Tetracycline (2)  ·  Tigecycline (2)  ·  Vancomycin (2)  ·  Amdinocillin Pivoxil (1)  ·  Ampicillin (1)  ·  Cefazolin (1)  ·  Cefepime (1)

Sponsors

Lund University (3)  ·  Central Hospital, Nancy, France (2)  ·  Fundación Pública Andaluza para la gestión de la Investigación en Sevilla (2)  ·  Mahidol University (2)  ·  Ankara City Hospital Bilkent (1)  ·  Assistance Publique Hopitaux De Marseille (1)  ·  Assiut University (1)  ·  Azienda Ospedaliera Universitaria Integrata Verona (1)  ·  Balgrist University Hospital (1)  ·  Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh (1)  ·  British University In Egypt (1)  ·  Cairo University (1)  ·  Centers for Disease Control and Prevention (1)  ·  Centre Hospitalier Universitaire de Besancon (1)  ·  Columbia University (1)

Countries

United States (9)  ·  Sweden (5)  ·  France (4)  ·  Germany (4)  ·  United Kingdom (4)  ·  Italy (3)  ·  Egypt (2)  ·  South Korea (2)  ·  Spain (2)  ·  Switzerland (2)  ·  Thailand (2)  ·  Bangladesh (1)  ·  Belgium (1)  ·  Brazil (1)  ·  Canada (1)

Top investigators

Adhiratha Boonyasiri, MD (1)  ·  Alberto Zangrillo, Prof (1)  ·  Alessandra Oliva, MD, PhD (1)  ·  Alison Holmes (1)  ·  Amy J Pickering, PhD (1)  ·  Andrew J Cohen, MD (1)  ·  Asmaa A Elsayed, Ph.D. (1)  ·  Barry C Fox, MD (1)  ·  Bradley Connor, MD (1)  ·  Branislav V Bajkin, MD, DMD, PhD (1)  ·  Bryan Coburn, MD, PhD (1)  ·  Byung-Wook Kim, MD, PhD (1)  ·  Cesar A Arias, MD, PhD, Msc (1)  ·  Christopher Polk, MD (1)

Results publications

PMID 10625102, PMID 10870281, PMID 11883966, PMID 12190139, PMID 12781508, PMID 14699540, PMID 15088029, PMID 15510357, PMID 15953905, PMID 16518713, PMID 16648771, PMID 16876044, PMID 16940094, PMID 17052624, PMID 17229548, PMID 17236918, PMID 17408924, PMID 17484797, PMID 17666691, PMID 17719384, PMID 17884515, PMID 18088870, PMID 18167394, PMID 18390528, PMID 18663500, PMID 18760616, PMID 19138601, PMID 19531419, PMID 19753908, PMID 20346713, PMID 20652078, PMID 21188333, PMID 21470751, PMID 21712864, PMID 22338284, PMID 22354306, PMID 23152221, PMID 23159124, PMID 23235637, PMID 23390473, PMID 23489756, PMID 24225610, PMID 24370576, PMID 24559212, PMID 24842194, PMID 25279397, PMID 25436105, PMID 25467569, PMID 26116842, PMID 26162260

NIH funding

2017 (2), 2016 (1), P01AI152999 (1), R01AI184756 (1)